pharma news, views and analysis - pharmaphorum.com

Trending

in News
UK accounts for 12% of cell and gene therapy trials – report
January 15, 2020 Share
X
UK accounts for 12% of cell and gene therapy trials – report
https://pharmaphorum.com/news/uk-accounts-for-12-of-cell-and-gene-therapy-trials-report/
in News
MorphoSys gets $750m from Incyte for anti-CD19 cancer drug
January 15, 2020 Share
X
MorphoSys gets $750m from Incyte for anti-CD19 cancer drug
https://pharmaphorum.com/news/morphosys-gets-750m-from-incyte-for-anti-cd19-cancer-drug/

Latest News

GSK’s CEO Walmsley aiming for six new approvals in 2020

GSK’s CEO Walmsley aiming for six new approvals in 2020

GlaxoSmithKline’s CEO Emma Walmsley has said the company hopes to get at least six new drug approvals in

X

GSK’s CEO Walmsley aiming for six new approvals in 2020

https://pharmaphorum.com/news/gsks-ceo-walmsley-aiming-for-six-new-approvals-in-2020/

Chasing Astellas, UK’s KaNDy heads to phase 3 with menopause drug

Chasing Astellas, UK’s KaNDy heads to phase 3 with menopause drug

UK biotech KaNDy Therapeutics is heading to phase 3 with its non-hormonal menopause drug, after a mid-stage trial

X

Chasing Astellas, UK’s KaNDy heads to phase 3 with menopause drug

https://pharmaphorum.com/news/chasing-astellas-uks-kandy-heads-to-phase-3-with-menopause-drug/

AZ axes phase 3 heart disease trial of fish oil drug Epanova

AZ axes phase 3 heart disease trial of fish oil drug Epanova

AstraZeneca has axed a large late-stage trial for its heart disease drug Epanova in patients with mixed dyslipidemia

X

AZ axes phase 3 heart disease trial of fish oil drug Epanova

https://pharmaphorum.com/news/az-axes-phase-3-trial-in-heart-disease/

Views & Analysis

Nine pharma trends for 2020

Nine pharma trends for 2020

Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for

X

Nine pharma trends for 2020

https://pharmaphorum.com/views-analysis-digital/nine-pharma-trends-for-2020/

Q&A: Medidata’s Christian Hebenstreit on clinical trials trends for 2020

Q&A: Medidata’s Christian Hebenstreit on clinical trials trends for 2020

We spoke to Christian Hebenstreit, senior VP and general manager, EMEA at Medidata, a Dassault Systèmes company, to

X

Q&A: Medidata’s Christian Hebenstreit on clinical trials trends for 2020

https://pharmaphorum.com/r-d/views-analysis-r-d/qa-medidatas-christian-hebenstreit-on-clinical-trials-trends-for-2020/

Four ways AI and machine learning will transform healthcare in 2020

Four ways AI and machine learning will transform healthcare in 2020

From AI assisted robotic surgery to clinical diagnosis, image analysis and administrative tasks, the use of artificial intelligence

X

Four ways AI and machine learning will transform healthcare in 2020

https://pharmaphorum.com/digital/four-ways-ai-and-machine-learning-will-transform-healthcare-in-2020/

Debates & Insights

Navigating new frontiers: Ways to find space in the future RA market

Navigating new frontiers: Ways to find space in the future RA market

Overview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15

X

Navigating new frontiers: Ways to find space in the future RA market

https://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/

Understanding blockchain – a practical guide for life sciences companies

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

X

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Partner Content

HPAPI 2020 Conference – Programme Announced

HPAPI 2020 Conference – Programme Announced

HPAPI Industry Insights

X

HPAPI 2020 Conference – Programme Announced

https://pharmaphorum.com/partner-content/hpapi-2020-conference-programme-announced/

13th Annual Pharma Resource Planning and Portfolio Management

13th Annual Pharma Resource Planning and Portfolio Management

Prioritizing Projects with Tools, Data, and Governance

X

13th Annual Pharma Resource Planning and Portfolio Management

https://pharmaphorum.com/events/13th-annual-pharma-resource-planning-and-portfolio-management/

3rd Annual Dermatology Drug Development Summit

3rd Annual Dermatology Drug Development Summit

Industry meeting on advancing derm drug development

X

3rd Annual Dermatology Drug Development Summit

https://pharmaphorum.com/events/3rd-annual-dermatology-drug-development-summit/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com